![]() |
市場調查報告書
商品編碼
1825961
2025年生醫光電全球市場報告Biophotonics Global Market Report 2025 |
近年來,生醫光電市場快速擴張,從2024年的832.6億美元成長到2025年的920.7億美元,複合年成長率為10.6%。過去一段時間的成長得益於醫學成像、疾病診斷和監測、生命科學研究、光學感測和光譜學以及雷射和光源技術的創新。
預計未來幾年生醫光電市場規模將快速成長,到2029年將達到1,478.4億美元,複合年成長率為12.6%。預測期內的成長可歸因於個人化醫療、精密農業、全球健康舉措、穿戴式和行動醫療設備、環境監測和安全。預測期內的主要趨勢包括微型化和照護現場設備、多模態成像、光遺傳學、機器學習和數據分析以及智慧成像探針。
生醫光電代表了光電與生物學的融合,形成了一個專注於光技術在生命科學和醫學領域應用的跨學科研究領域。其主要目標是在生物學領域內,從細胞、組織、分子和生物等多個層面研究、操控和監測生物過程。
生醫光電的主要技術領域包括體外和體內技術。體外技術是指在微生物、細胞和生物分子的自然生物環境之外進行研究的方法。此類研究通常在實驗室容器中進行,例如試管、燒瓶、培養皿和微量滴定板,通常稱為試管研究。生醫光電的各種應用包括透視成像、內部成像、光譜分子分析、表面成像、顯微鏡、光療法和生物感測器,並廣泛應用於診斷、治療、檢測及相關領域。
2025年春季美國關稅的突然上調及其引發的貿易摩擦對醫療保健領域產生了重大影響,尤其是對基本醫療設備、診斷設備和藥品的供應。醫院和醫療機構正疲於應對進口手術器械、診斷影像系統以及注射器和導管等消耗品不斷上漲的成本,而這些產品中的許多在國內的替代品有限。由於這些不斷上漲的成本給醫療保健預算帶來壓力,一些醫療機構正在推遲設備升級或將增加的費用轉嫁給患者。此外,原料和零件的關稅擾亂了關鍵藥品和醫療設備的生產,導致供應鏈延遲。作為應對措施,該行業正在採用多樣化的籌資策略,盡可能擴大本地生產,並遊說對關鍵醫療產品免關稅。
本研究報告是商業研究公司 (The Business Research Company) 新報告系列的一部分,該系列提供生醫光電市場統計數據,例如全球生醫光電市場規模、各地區市場佔有率、生醫光電競爭對手的市場佔有率、詳細的生醫光電市場細分、市場趨勢和商業機會,以及您在生醫光電行業取得成功所需的數據。本生醫光電市場研究報告對該行業的現狀和未來趨勢進行了詳細分析,為您提供所需的一切觀點。
未來五年12.6%的成長率預測比我們先前的預測略有下降0.2%。這一下降主要源自於美國與其他國家之間關稅的影響。徵收關稅可能會擾亂美國的醫療診斷業務,因為這會增加從日本和以色列進口的光學相干斷層掃描系統和雷射手術器械的成本,從而可能降低手術的準確性並增加資本成本。由於互惠關稅以及日益加劇的貿易緊張局勢和限制對全球經濟和貿易的負面影響,其影響也可能更為廣泛。
由於微創手術需求的不斷成長,生醫光電市場正在經歷顯著成長。光學工程和成像技術的進步在增強微創手術方面發揮關鍵作用,使遠端內部位置的組織操作能夠即時可視化。例如,2023年1月,美國領先的機器人產品製造商Intuitive Surgical Inc.報告稱,2022年使用Vinci Surgical Systems進行的手術約有1,875,000例,比2021年使用Vinci Surgical Systems進行的1,594,000例成長了18%。全球每年微創手術數量的增加直接推動了生醫光電市場收益的成長。
預計生醫光電市場的成長將受到慢性病盛行率上升的推動。慢性病的特徵是持續性,持續時間超過三個月,並且在世界各地普遍存在。生醫光電在這些疾病的早期發現、持續監測和有效治療中發揮關鍵作用,提供非侵入性影像和診斷解決方案。這可以改善患者的治療效果,同時控制醫療成本。根據世界衛生組織 (WHO) 2022 年 9 月發布的報告,慢性病佔全球死亡人數的很大一部分,其中 74% 的死亡可歸因於慢性病。這些慢性病包括各種疾病,例如心血管疾病、癌症、慢性呼吸系統疾病和糖尿病。因此,慢性病發生率的上升刺激了生醫光電市場的成長。
推動生醫光電市場發展的顯著趨勢之一是生物技術領域對先進技術的採用。蘇格蘭聖安德魯斯大學的一支科學家團隊發明了一種螢光顯微鏡技術。這種創新方法能夠以最小的損傷對精細的生物樣本進行成像,尤其是在神經科學和生物醫學應用中。預計這種侵入性較小的光學技術將在不久的將來徹底改變生物醫學領域。因此,生醫光電市場對新興尖端技術的重視程度日益提升。
生醫光電市場的主要企業正專注於開發先進的技術解決方案,例如尖端運算工具,以提高成像精度、增強診斷能力並支援個人化醫療。尖端計算工具是專門的軟體和演算法,旨在分析來自醫學影像和分子診斷等領域的複雜數據。這些工具利用機器學習和人工智慧,提高了生醫光電應用的精確度和效率。例如,2023 年 7 月,美國生物技術公司 FOXO Technologies Inc. 推出了旨在變革表觀遺傳學數據分析的生物資訊服務。這些服務提供了一個全面的平台,旨在滿足學術、醫療保健和製藥行業客戶的需求。關鍵發展包括原始 DNA 甲基化微陣列數據的處理和分析以及高級分析,例如表觀基因組關聯研究 (EWAS) 和人工智慧主導的表觀遺傳生物標記開發。
2024年5月,美國製造公司布魯克公司(Bruker Corporation)以3.926億美元收購了NanoString Technologies。此次收購增強了布魯克在太空生物學領域的能力,尤其是其nCounter分析系統,能夠靈敏、準確地分析基因和蛋白質的表達。 NanoString Technologies是美國的生命科學工具供應商,致力於轉化研究和分子診斷。
生醫光電市場的主要企業包括賽默飛世爾科技公司、OpGen公司、NU Skin Enterprises公司、IPG Photonics公司、Idex公司、東芝公司、堀場製作所、Precision Photonics公司、羅氏集團、通用電氣公司、荷蘭皇家飛利浦公司、Affymeas、AndEIortrix、Fenam、Bamak、Mam 這些公司、Fenam、Ftidamone、B.Senk、Yamuid參與公司、H兩身公司、Af 這些公司、Henam、Funamidet. Photonics公司、Lumenis公司、奧林巴斯公司、PerkinElmer公司、Zecotek Photonics公司、Zenalux Biomedical公司、Glenbrook Technologies公司、Oxford Instruments公司、Lumicks公司、Creoptix公司、ThinkCyte公司、PhotoPharmics公司、Impedimedcks公司和Bioptics公司。
2024年,生醫光電市場最大的地區是北美。西歐是生醫光電市場的第二大地區。生醫光電市場報告涵蓋的地區包括亞太地區、西歐、東歐、北美、南美、中東和非洲。
生醫光電市場報告涵蓋的國家:澳洲、巴西、中國、法國、德國、印度、印尼、日本、俄羅斯、韓國、英國、美國、義大利、西班牙和加拿大。
Biophotonics represents the convergence of photonics and biology, forming a multidisciplinary research field focused on the application of light-based technologies in life sciences and medical domains. Its primary purpose is to investigate, manipulate, and monitor biological processes at multiple levels within the realm of biology, spanning cellular, tissue, molecular, and organismic aspects.
The key technological segments in biophotonics involve in-vitro and in-vivo methodologies. In-vitro approaches are centered around the examination of microorganisms, cells, and biological molecules outside of their natural biological environments. These investigations are typically conducted in laboratory vessels like test tubes, flasks, Petri dishes, and microtiter plates, commonly known as test-tube studies. Various applications within biophotonics encompass see-through imaging, internal imaging, spectromolecular analysis, surface imaging, microscopy, light-based therapies, biosensors, and more, with broad utility across sectors such as diagnostics, therapeutics, testing, and related domains.
Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.
The sharp rise in U.S. tariffs and the resulting trade tensions in spring 2025 are having a significant impact on the healthcare sector, especially in the supply of essential medical devices, diagnostic equipment, and pharmaceuticals. Hospitals and healthcare providers are grappling with higher costs for imported surgical tools, imaging systems, and consumables like syringes and catheters, many of which have limited domestic substitutes. These escalating expenses are putting pressure on healthcare budgets, prompting some providers to delay equipment upgrades or pass increased costs on to patients. Furthermore, tariffs on raw materials and components are disrupting the manufacturing of vital drugs and devices, leading to supply chain delays. In response, the industry is adopting diversified sourcing strategies, expanding local production where feasible, and pushing for tariff exemptions on critical medical products.
The biophotonics market research report is one of a series of new reports from The Business Research Company that provides biophotonics market statistics, including biophotonics industry global market size, regional shares, competitors with a biophotonics market share, detailed biophotonics market segments, market trends and opportunities, and any further data you may need to thrive in the biophotonics industry. This biophotonics market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
The biophotonics market size has grown rapidly in recent years. It will grow from $83.26 billion in 2024 to $92.07 billion in 2025 at a compound annual growth rate (CAGR) of 10.6%. The growth in the historic period can be attributed to medical imaging advancements, disease diagnosis and monitoring, life sciences research, optical sensing and spectroscopy, laser and light source innovations.
The biophotonics market size is expected to see rapid growth in the next few years. It will grow to $147.84 billion in 2029 at a compound annual growth rate (CAGR) of 12.6%. The growth in the forecast period can be attributed to personalized medicine, precision agriculture, global health initiatives, wearable and mobile health devices, environmental monitoring and safety. Major trends in the forecast period include miniaturization and point-of-care devices, multimodal imaging, optogenetics, machine learning and data analytics, smart imaging probes.
The forecast of 12.6% growth over the next five years reflects a slight reduction of 0.2% from the previous projection. This reduction is primarily due to the impact of tariffs between the US and other countries. The imposition of tariffs may disrupt U.S. medical diagnostics by increasing costs for optical coherence tomography systems and laser surgical tools imported from Japan and Israel, potentially reducing precision in procedures and raising equipment expenses. The effect will also be felt more widely due to reciprocal tariffs and the negative effect on the global economy and trade due to increased trade tensions and restrictions.
The biophotonics market is experiencing significant growth, driven by the rising demand for minimally invasive surgeries. Advances in optical engineering and imaging technologies are playing a key role in enhancing minimally invasive procedures, allowing for real-time visualization of tissue manipulation at remote internal locations. For example, in January 2023, Intuitive Surgical Inc., a leading US-based manufacturer of robotic products, reported that approximately 1,875,000 surgical procedures were performed using Vinci Surgical Systems in 2022. This represents an 18% increase from the 1,594,000 procedures conducted with Vinci Surgical Systems in 2021. The growing number of minimally invasive surgeries performed globally each year is directly contributing to the revenue growth in the biophotonics market.
Anticipated to fuel the biophotonics market's growth is the rising prevalence of chronic conditions. Chronic conditions, characterized by their persistent nature lasting three months or longer, are prevalent worldwide. Biophotonics plays a crucial role in early detection, continuous monitoring, and effective treatment of these conditions, offering non-invasive imaging and diagnostic solutions. This facilitates improved patient outcomes while simultaneously curbing healthcare costs. A September 2022 report from the World Health Organization (WHO) disclosed that chronic diseases are responsible for a significant portion of global mortality, with 74% of all deaths attributed to these conditions. This encompasses a range of chronic diseases, including cardiovascular ailments, cancer, chronic respiratory diseases, and diabetes. Hence, the biophotonics market's growth is spurred by the increasing incidence of chronic conditions.
A notable trend driving the biophotonics market is the introduction of advanced techniques in the field of biotechnology. An exemplary development comes from a team of scientists at the University of St. Andrews in Scotland, who devised a fluorescence microscopy technique. This innovative method allows for the imaging of delicate biological samples with minimal damage, particularly in neuroscience and biomedicine applications. Such low-impact optical techniques are anticipated to revolutionize the realm of biomedicine in the near future. As a result, the biophotonics market is witnessing a growing emphasis on novel and cutting-edge techniques.
Leading companies in the biophotonics market are focusing on developing advanced technological solutions, such as cutting-edge computational tools, to improve imaging precision, enhance diagnostics, and support personalized medicine. Advanced computational tools are specialized software and algorithms designed to analyze complex data from fields like medical imaging and molecular diagnostics. By leveraging machine learning and AI, these tools increase the accuracy and efficiency of biophotonics applications. For example, in July 2023, FOXO Technologies Inc., a US-based biotechnology company, launched bioinformatics services aimed at transforming epigenetic data analysis. These services offer a comprehensive platform designed to meet the needs of clients in academia, healthcare, and the pharmaceutical industry. Key features include the processing and analysis of raw DNA methylation microarray data, along with advanced analyses such as epigenome-wide association studies (EWAS) and AI-driven epigenetic biomarker development.
In May 2024, Bruker Corporation, a US-based manufacturing company, acquired NanoString Technologies for $392.6 million. This acquisition will strengthen Bruker's capabilities in spatial biology, particularly with their nCounter Analysis System, which enables high-sensitivity and precision profiling of gene and protein expression. NanoString Technologies is a US-based provider of life science tools for translational research and molecular diagnostic products.
Major companies operating in the biophotonics market include Thermo Fisher Scientific Inc., OpGen Inc., NU Skin Enterprises Inc., IPG Photonics Corporation, Idex Corporation, Toshiba Corporation, Horiba Ltd., Precision Photonics Corp, Roche Group, General Electric Company, Koninklijke Philips NV, Affymetrix Inc., Andor Technology Ltd., Becton Dickinson & Co, Carl Zeiss AG, FEI Company, Hamamatsu Photonics KK, Lumenis Ltd., Olympus Corporation, PerkinElmer Inc., Zecotek Photonics Inc., Zenalux Biomedical Inc., Glenbrook Technologies Inc., Oxford Instruments PLC, Lumicks BV, Creoptix AG, ThinkCyte Inc., PhotoPharmics Inc., Impedimed Ltd., Bioptics Inc.
North America was the largest region in the biophotonics market in 2024. Western Europe was the second largest region in the biophotonics market. The regions covered in the biophotonics market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
The countries covered in the biophotonics market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Italy, Spain, Canada
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
Biophotonics Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.
This report focuses on biophotonics market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Where is the largest and fastest growing market for biophotonics ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The biophotonics market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.
The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.